8-K current report · filed Oct 16, 2026

REGENXBIO Inc. (RGNX) 8-K Current Report: October 16, 2026

Item 5.02RGNX overview

Short answer

REGENXBIO Inc. (RGNX) filed an 8-K current report with the SEC on October 16, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers). Kenneth T. Mills resigning as director effective October 21, 2026 to lead another company.

REGENXBIO Inc. 8-K event analysis

AI summary of each reported item and its exhibits

Item 5.02 · Departure/Election of Directors or Officers

  • Kenneth T. Mills resigning as director effective October 21, 2026 to lead another company
  • Departure unrelated to disagreements, reducing apparent governance or strategic disruption risk
  • George Migausky appointed independent Chairman, strengthening board independence
  • Daniel Tassé relinquishing Lead Independent Director role but remaining on the Board

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other REGENXBIO Inc. 8-K filings

Get the next RGNX 8-K as it lands

Follow RGNX for push alerts, or ask the research agent what this filing means.